XML 22 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Investment in Available for Sale Marketable Securities
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Investment In Marketable Securities [Abstract]    
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

The Company’s investment in marketable equity securities is being held for an indefinite period. Cost basis of marketable securities held as of March 31, 2021 and December 31, 2020 was $42,720 and accumulated unrealized losses were $41,073 and $41,296 as of March 31, 2021 and December 31, 2020, respectively. The fair market value of available for sale marketable securities was $1,647 as of March 31, 2021, based on 178,000 shares of common stock held in one entity with an average per share market price of approximately $0.01.

  

Net recognized gains (losses) on equity investments were as follows:

 

   Three Months Ended
   March 31,
   2021  2020
Net realized gains (losses) on investment sold  $—     $(2,142)
Net unrealized gains (losses) on investments still held   223    (16,644)
           
Total  $223   $(18,786)

 

 

The reconciliation of the investment in marketable securities is as follows for the three months ended March 31, 2021 and 2020:

 

   March 31,  March 31,
   2021  2020
Balance – December 31  $1,424   $44,766 
Additions   —      —   
Proceeds on sales of securities   —      (14,955)
Recognized gain (loss)   223    (18,786)
Balance – March 31  $1,647   $11,025 

 

NOTE 3 — INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES


The Company’s investments in marketable equity securities are being held for an indefinite period and thus have been classified as available for sale. Cost basis of securities held as of December 31, 2020 and 2019 was $42,720 and $708,541, respectively, and accumulated unrealized losses were $41,296 and $663,775 as of December 31, 2020 and 2019, respectively. The fair market value of available for sale marketable securities was $1,424 as of December 31, 2020, based on 178,000 shares of common stock held in one entity with a per share market price of approximately $0.008.


Net recognized gains (losses) on equity investments were as follows:


   Years Ended 
   December 31, 
   2020   2019 
Net realized gains (losses) on investment sold or assigned  $(2,543)  $(49,757)
Net unrealized gains (losses) on investments still held   (19,873)   (110,692)
           
Total  $(22,416)  $(160,449)

The reconciliation of the investment in marketable securities is as follows for the years ended December 31, 2020 and 2019:


   December 31,   December 31, 
   2020   2019 
Balance – January1  $44,766   $33,917 
Additions   -    240,000 
Proceeds on sales of securities   (17,009)   (68,702)
Assignment of securities as compensation   (3,917)   - 
Recognized losses   (22,416)   (160,449)
Balance – December 31  $1,424   $44,766